chartexchange
ESTUTC-5 New York
Sign up
FeedbackDocs

TRAW
Traws Pharma, Inc. Common Stock
stockNASDAQ

At CloseNov 9, 2026
0.24USD0.000%(0.00)123,777
Pre-marketNov 10, 2026 9:26:30 AM EST
0.2547USD+6.125%(+0.0147)
After-hoursNov 9, 2026 4:56:30 PM EST
0.252979USD+5.136%(+0.012358)
0.2100Bid0.2800Ask0.0800Spread
Loading…
Loading…
Market Cap
3.55M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
HQ
Newtown, Pennsylvania, USA
Previous Close
$0.24
Beta
1.70
52-Week High
$3.23 2026-05-11
52-Week Low
$0.22 2026-11-05
SMA 50
$0.45
SMA 200
$1.11
Avg. Vol 10D
185,272
Avg. Vol 30D
179,948
Avg. Vol 90D
455,232
Relative Vol
0.67
Shares Out
15.37M
Float
10.86M
Free Float %
70.69%
Short Interest
685,721
Short Interest %
5.74%
Days to Cover
3.72
On/Off Exchange
40%/60%
Short Vol %
19.16%
Short Vol % (off-exch)
16.69%
Borrow Fee
22.3800%
Borrow Avail.
60,000
FTDs
20,197
FTDs 30d avg
11,393
FTDs 30d high
81,485
Next Earnings
Nov 12, 2026 (2d)
Last Split
Sep 23, 2024 · 1-for-25 (reverse)
Revenue (TTM)
0
Net Income (TTM)
-21.6M
TRAW Profile

onconova therapeutics, inc. (nasdaq: ontx) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. using a proprietary chemistry platform, onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. onconova has three product candidates in clinical trials and six active pre-clinical programs. onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.

TRAW Performance
PeriodPriceDateChangeBeta
1W0.302026-11-03-23.54%2.889
1M0.452026-10-09-48.14%2.819
3M0.542026-08-10-57.24%2.327
6M2.022026-05-11-88.57%1.484
1Y1.942025-11-10-88.10%1.698
2Y5.412024-11-11-95.73%—
TRAW Stock Summary

Traws Pharma, Inc. Common Stock (NASDAQ:TRAW) stock price today is $0.23, and today's volume is 119,698. TRAW is down 3.792% today. The 30 day average volume is 179,948. TRAW market cap is $3.55M with 15.37M shares outstanding.